LEXINGTON, Ky. (Aug. 3, 2020) — The University of Kentucky recently was awarded a Centers of Biomedical Research Excellence (COBRE) grant to study translational chemical biology from the National Institutes of General Medical Sciences, part of the National Institutes of Health. The $11.2 million grant will fund UK's Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation (CPRI).
This COBRE Phase 1 funding will provide campuswide junior faculty research and career development support, core infrastructure and pilot grants in the translational chemical biology research space. Critical infrastructure, in the form of cores, will support advanced research across UK campus: Chang-Guo Zhan directs